Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios
- PMID: 12404608
- DOI: 10.1002/1099-1077(200010)15:1+<::AID-HUP247>3.0.CO;2-S
Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios
Abstract
The use of antihistamines (AHs) has until recently been associated with a number of undesirable side effects, the most troublesome of which is sedation. There are two aspects to sedation. The first, an objectively determined measure based on the results of psychometric tests from controlled trials, and the second, the subject's response to the administration of a drug. Since AHs are largely used in ambulant patients, a complete evaluation of sedation should be performed through standardised objective and subjective tests, shown to be sensitive to the central effects of AHs.An extensive review of the literature identified 76 studies of H(1) receptor antagonists in healthy volunteers, in which assessment of sedation was the primary objective. Results from studies published in peer-reviewed journals which employed a placebo condition as well as a positive internal control using a crossover design were analysed to determine the extent to which a particular antihistamine produced impairments on a battery of psychometric tests. The impairment index for each antihistamine was calculated and subsequently compared with the impairment index obtained for all other AHs.The calculation of this proportional impairment ratio enabled the sedative potential of an individual antihistamine to be identified relative to all other AHs and thus allowed the ranking of AHs with respect to their ability to cause impairments of cognitive and psychomotor function.Findings from this review clearly demonstrate that there are distinct classes of AHs with respect to their ability to impair cognitive function and psychomotor performance. Copyright 2000 John Wiley & Sons, Ltd.
Similar articles
-
Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios.Hum Psychopharmacol. 2008 Oct;23(7):555-70. doi: 10.1002/hup.962. Hum Psychopharmacol. 2008. PMID: 18618902 Review.
-
Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.PLoS One. 2014 Dec 12;9(12):e114336. doi: 10.1371/journal.pone.0114336. eCollection 2014. PLoS One. 2014. PMID: 25501360 Free PMC article. Review.
-
Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects.Clin Exp Allergy. 1999 Jul;29 Suppl 3:133-42. doi: 10.1046/j.1365-2222.1999.0290s3133.x. Clin Exp Allergy. 1999. PMID: 10444227 Review.
-
Clinical outcomes and adverse effect monitoring in allergic rhinitis.J Allergy Clin Immunol. 2005 Mar;115(3 Suppl 1):S390-413. doi: 10.1016/j.jaci.2004.12.014. J Allergy Clin Immunol. 2005. PMID: 15746880 Review.
-
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.Hum Psychopharmacol. 2003 Dec;18(8):611-8. doi: 10.1002/hup.538. Hum Psychopharmacol. 2003. PMID: 14696020 Clinical Trial.
Cited by
-
Cetirizine: a review of its use in allergic disorders.Drugs. 2004;64(5):523-61. doi: 10.2165/00003495-200464050-00008. Drugs. 2004. PMID: 14977391
-
Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein.Pharm Res. 2007 Feb;24(2):318-27. doi: 10.1007/s11095-006-9149-4. Epub 2006 Dec 19. Pharm Res. 2007. PMID: 17180728
-
Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine.Pharmacol Res Perspect. 2019 Jul 12;7(4):e00499. doi: 10.1002/prp2.499. eCollection 2019 Aug. Pharmacol Res Perspect. 2019. PMID: 31338198 Free PMC article. Clinical Trial.
-
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.Arch Dermatol Res. 2012 May;304(4):263-72. doi: 10.1007/s00403-011-1192-2. Epub 2011 Dec 1. Arch Dermatol Res. 2012. PMID: 22130869 Free PMC article. Clinical Trial.
-
New insights into the second generation antihistamines.Drugs. 2001;61(2):207-36. doi: 10.2165/00003495-200161020-00006. Drugs. 2001. PMID: 11270939 Review.
LinkOut - more resources
Full Text Sources